We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Smartphone Application Detects Atrial Fibrillation

By HospiMedica International staff writers
Posted on 26 Jun 2012
A novel cardiac application for the iPhone and most smartphones detects not only heart rate, but also heart rhythm, respiration rate, and blood oxygen saturation (SpO2) using the phone’s built-in video camera.

Developed by researchers at the Worcester Polytechnic Institute (WPI, MA, USA), the app uses the smartphone’s camera and light-source, detecting small changes in skin color and the appearance of underlying blood vessels at 30 frames-per-second (fps) when the index finger is held over the camera for a minute or two. More...
Due to the nature of the light-source, the app will be compatible with the iPhone and most other smartphones, but not with the iPad, which uses a different enclosure.

The phone will display a green indicator when the reading is considered normal and a red one when an abnormal heart rhythm is detected. A numeric heart rate is also displayed, along with a verbal description of the rhythm on a slider scale. A symptom recorder is also included, which allows sensations and other symptoms to be typed in for reference. The data can be emailed to a doctor or clinic, or kept as a record for future visits.

Although not designed to replace any diagnostic devices, it could be used as a screening tool, as well as for use for patients with paroxysmal atrial fibrillation (AF), registering intermittent AF episodes over longer periods of time, either in existing patients (for monitoring purposes) or in new patients for detection of AF. For these purposes, a watchband type device might function to continuously acquire data, or the app could be used once the patient experiences symptoms.

The app has been tested in 60 patients with AF at the at the University of Massachusetts (UMass; USA) Memorial Medical Center. In all patients, AF was correctly identified, giving it 100% sensitivity. The app is pending approval by the US Food and Drug Administration (FDA).

“AFib is so common, but many people have no symptoms, or subtle symptoms like getting winded. This tool will be very helpful because AFib is so hard and expensive to diagnose,” said David McManus, MD, a cardiologist at UMass, chief clinician of the clinical trial of the app. “The time required to hold one’s finger down will likely be decreased in the final version of the app, perhaps to a minute or less.”

Related Links:

Worcester Polytechnic Institute
University of Massachusetts


Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Portable Digital Floor Scale
DR400C
New
Infusion System
SIGMA Spectrum
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.